| Timing of antiviral treatment initiation is critical to reduce SARS‐CoV‐2 viral load A Gonçalves, J Bertrand, R Ke, E Comets, X De Lamballerie, D Malvy, ... CPT: pharmacometrics & systems pharmacology 9 (9), 509-514, 2020 | 229 | 2020 |
| Quantifying the relationship between SARS-CoV-2 viral load and infectiousness A Marc, M Kerioui, F Blanquart, J Bertrand, O Mitja, M Corbacho-Monné, ... Elife 10, e69302, 2021 | 127 | 2021 |
| Performance comparison of various maximum likelihood nonlinear mixed-effects estimation methods for dose–response models EL Plan, A Maloney, F Mentré, MO Karlsson, J Bertrand The AAPS journal 14, 420-432, 2012 | 75 | 2012 |
| Guide pour la mise en œuvre de la gouvernance en appui au développement durable des territoires H Rey-Valette, M Pinto, P Maurel, E Chia, PY Guihéneuf, L Michel, ... auto-saisine, 2011 | 71 | 2011 |
| Dependence of Efavirenz- and Rifampicin-Isoniazid–Based Antituberculosis Treatment Drug-Drug Interaction on CYP2B6 and NAT2 Genetic Polymorphisms … J Bertrand, C Verstuyft, M Chou, L Borand, P Chea, KH Nay, FX Blanc, ... The Journal of infectious diseases 209 (3), 399-408, 2014 | 66 | 2014 |
| Population pharmacokinetic-pharmacogenetic study of nevirapine in HIV-infected Cambodian patients M Chou, J Bertrand, O Segeral, C Verstuyft, L Borand, E Comets, ... Antimicrobial agents and chemotherapy 54 (10), 4432-4439, 2010 | 61 | 2010 |
| Influence of pharmacogenetics on indinavir disposition and short-term response in HIV patients initiating HAART J Bertrand, JM Treluyer, X Panhard, A Tran, S Auleley, E Rey, ... European journal of clinical pharmacology 65, 667-678, 2009 | 57 | 2009 |
| Comparison of model-based tests and selection strategies to detect genetic polymorphisms influencing pharmacokinetic parameters J Bertrand, E Comets, F Mentre Journal of biopharmaceutical statistics 18 (6), 1084-1102, 2008 | 56 | 2008 |
| Therapeutic window of dopamine D2/3 receptor occupancy to treat psychosis in Alzheimer’s disease S Reeves, E McLachlan, J Bertrand, F D’Antonio, S Brownings, A Nair, ... Brain 140 (4), 1117-1127, 2017 | 54 | 2017 |
| Pharmacogenetics and population pharmacokinetics: impact of the design on three tests using the SAEM algorithm J Bertrand, E Comets, CM Laffont, M Chenel, F Mentré Journal of pharmacokinetics and pharmacodynamics 36, 317-339, 2009 | 47 | 2009 |
| Multiple genetic variants predict steady-state nevirapine clearance in HIV-infected Cambodians J Bertrand, M Chou, DM Richardson, C Verstuyft, PD Leger, F Mentré, ... Pharmacogenetics and genomics 22 (12), 868-876, 2012 | 44 | 2012 |
| A population pharmacokinetic model to guide clozapine dose selection, based on age, sex, ethnicity, body weight and smoking status S Reeves, J Bertrand, SJ Obee, S Hunter, R Howard, RJ Flanagan British Journal of Clinical Pharmacology 90 (1), 135-145, 2024 | 35 | 2024 |
| Development of a complex parent-metabolite joint population pharmacokinetic model J Bertrand, CM Laffont, F Mentré, M Chenel, E Comets The AAPS journal 13, 390-404, 2011 | 35 | 2011 |
| Mathematical expressions of the pharmacokinetic and pharmacodynamic models implemented in the PFIM software A Dubois, J Bertrand, F Mentré UMR738, INSERM, Paris Diderot University, 2011 | 34 | 2011 |
| Some alternatives to asymptotic tests for the analysis of pharmacogenetic data using nonlinear mixed effects models J Bertrand, E Comets, M Chenel, F Mentré Biometrics 68 (1), 146-155, 2012 | 27 | 2012 |
| Multiple single nucleotide polymorphism analysis using penalized regression in nonlinear mixed-effect pharmacokinetic models J Bertrand, DJ Balding Pharmacogenetics and genomics 23 (3), 167-174, 2013 | 26 | 2013 |
| Mathematical expressions of the pharmacokinetic and pharmacodynamic models implemented in the Monolix software J Bertrand, F Mentré Paris Diderot University, 1-68, 2008 | 25 | 2008 |
| Can a flavored spray (pill glide) help children swallow their medicines? A pilot study M Jagani, H Legay, SR Ranmal, J Bertrand, K Ooi, C Tuleu Pediatrics 138 (6), 2016 | 23 | 2016 |
| Therapeutic D2/3 receptor occupancies and response with low amisulpride blood concentrations in very late‐onset schizophrenia‐like psychosis (VLOSLP) S Reeves, K Eggleston, E Cort, E McLachlan, S Brownings, A Nair, ... International journal of geriatric psychiatry 33 (2), 396-404, 2018 | 22 | 2018 |
| Short-term memory predictions across the lifespan: Monitoring span before and after conducting a task JM Bertrand, CJA Moulin, C Souchay Memory 25 (5), 607-618, 2017 | 22 | 2017 |
